Murray Cod Australia (MCA) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
13 Jun, 2025Executive summary
Achieved record biomass of 1,073 tonnes in FY24, with 5.1 million fish in stock and significant production scale-up at Stanbridge site.
Revenue increased 22% year-over-year to $30.6 million, driven by higher average sale price and growing export sales, especially in Southeast Asia.
Launched Aquna Gold Caviar, expanding product offerings and targeting luxury markets.
Secured $20.4 million in equity capital and a $20 million financing facility to fund growth and Stanbridge completion.
Financial highlights
Total revenue rose to $30.64M from $25.11M, up 22% compared to the previous year.
Net loss before tax improved to ($6.2M) from ($7.3M), a 15% reduction year-over-year.
Cash in bank at year-end was $20.75M.
Tonnes harvested decreased by 18% to 353t, but biomass value increased 64% to $32.1M.
Average sale price per kg increased 9% to $27.08.
Outlook and guidance
Expecting a managed increase in volume of larger grade fish (2.5kg+) for sale, prioritizing restaurant and hospitality sectors.
Anticipates further increases in average sale price per kg as biomass reaches optimum size.
Expansion of export sales to Southeast Asia and new markets in the Middle East, Europe, UK, and North America underway.
Latest events from Murray Cod Australia
- Revenue up 40% year-over-year, but net loss of $4.1 million driven by higher costs.MCA
H1 20268 Mar 2026 - Record profit, infrastructure scale-up, and all resolutions passed, setting up FY26 growth.MCA
AGM 202518 Nov 2025 - Sales up 45% year-over-year, with expanded retail footprint and strong export growth.MCA
Q1 2026 TU27 Oct 2025 - Record profitability and a $17m capital raise position the business for premium market growth.MCA
Investor Presentation25 Sep 2025 - Record profitability and biomass growth set the stage for accelerated sales and cash generation in FY26.MCA
Investor Presentation23 Sep 2025 - FY25 saw a $8.56M profit, 808% EBITDA growth, and record asset expansion.MCA
H2 202528 Aug 2025 - Net profit swung to $1.33m as revenue, biological assets, and export channels expanded.MCA
H1 20255 Jun 2025